Weiss Asset Management LP
Source: SEC Form 13F · as of Mar 2026Weiss Asset Management LP holds 16 biotech & pharma companies tracked by BioSniper, totaling $186.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$186.3M
BioSniper AIPage evidence connected
Prepared research question
What matters most for AMICUS THERAPEUTICS, INC. (FOLD)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| FOLDAMICUS THERAPEUTICS, INC. | 3,872,902 | $56.0M |
| MLTXMoonLake Immunotherapeutics | 1,708,328 | $31.8M |
| APLSApellis Pharmaceuticals, Inc. | 700,000 | $28.2M |
| ALMSALUMIS INC. | 1,097,417 | $24.2M |
| CNTACentessa Pharmaceuticals plc | 510,407 | $20.3M |
| COGTCogent Biosciences, Inc. | 346,104 | $13.3M |
| MRNAModerna, Inc. | 93,720 | $4.8M |
| RNAAtrium Therapeutics Inc. | 240,701 | $3.2M |
| PTGXProtagonist Therapeutics, Inc | 9,780 | $1.0M |
| RVMDREVOLUTION MEDICINES, INC. | 9,097 | $885K |
| SLNOSOLENO THERAPEUTICS INC | 23,000 | $770K |
| EXELEXELIXIS, INC. | 11,580 | $497K |
| KURAKura Oncology, Inc. | 52,687 | $428K |
| ARVNARVINAS, INC. | 36,305 | $385K |
| XERSXeris Biopharma Holdings, Inc. | 50,001 | $290K |
| REGNREGENERON PHARMACEUTICALS, INC. | 336 | $260K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.